These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4036700)

  • 21. Hypertriglyceridemia and atherosclerosis analysis of an abnormal lipoprotein system and potential beneficial effects of triglyceride lowering therapy.
    Eisenberg S
    Adv Exp Med Biol; 1985; 183():73-84. PubMed ID: 4036705
    [No Abstract]   [Full Text] [Related]  

  • 22. Statins as effectors of key activities involved in apoE-dependent VLDL metabolism: review and hypothesis.
    Dergunov AD; Visvikis-Siest S; Siest G
    Vascul Pharmacol; 2008; 48(2-3):70-5. PubMed ID: 18221919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of human high density lipoproteins, anti-apolipoproteins CII and CIII, and hydrolysis of very low density lipoprotein (VLDL) cholesterol ester on VLDL catabolism in vitro.
    Liu BW; Hynd BA; Kashyap ML
    Biochem Biophys Res Commun; 1984 Jun; 121(3):946-52. PubMed ID: 6588972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of lipoprotein lipase by synthetic fragments of apolipoprotein C-II.
    Smith LC; Voyta JC; Catapano AL; Kinnunen PK; Gotto AM; Sparrow JT
    Ann N Y Acad Sci; 1980; 348():213-23. PubMed ID: 6930927
    [No Abstract]   [Full Text] [Related]  

  • 25. Characterization of lipoprotein lipase activators from equine plasma.
    Le Goff D; Hannan J; Maboundou JC; Ayrault-Jarrier M
    Biochem Int; 1992 Dec; 28(5):795-804. PubMed ID: 1288492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoproteins A and C; interaction with lipid monolayers.
    Jackson RL; Pattus F; de Haas G; Demel RA
    Ann N Y Acad Sci; 1980; 348():75-86. PubMed ID: 6772080
    [No Abstract]   [Full Text] [Related]  

  • 27. Apolipoprotein C-II deficiency. The role of apolipoprotein C-II in the hydrolysis of triacylglycerol-rich lipoproteins.
    Haberbosch W; Poli A; Baggio G; Fellin R; Gnasso A; Augustin J
    Biochim Biophys Acta; 1984 Mar; 793(1):49-60. PubMed ID: 6704413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The hypochylomicronemic effect of beta,beta'-methyl-substituted hexadecanedioic acid (MEDICA 16) is mediated by a decrease in apolipoprotein C-III.
    Frenkel B; Mayorek N; Hertz R; Bar-Tana J
    J Biol Chem; 1988 Jun; 263(17):8491-7. PubMed ID: 3372539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substitutions of glutamate 110 and 111 in the middle helix 4 of human apolipoprotein A-I (apoA-I) by alanine affect the structure and in vitro functions of apoA-I and induce severe hypertriglyceridemia in apoA-I-deficient mice.
    Chroni A; Kan HY; Kypreos KE; Gorshkova IN; Shkodrani A; Zannis VI
    Biochemistry; 2004 Aug; 43(32):10442-57. PubMed ID: 15301543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of lipid transfer proteins on lipoprotein lipase induced transformation of VLDL and HDL.
    Murdoch SJ; Breckenridge WC
    Biochim Biophys Acta; 1996 Oct; 1303(3):222-32. PubMed ID: 8908157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mechanism of action of hypolipemic drugs].
    Fruchart JC
    J Pharm Belg; 1992; 47(4):345-50. PubMed ID: 1403601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipoprotein fractions and receptors: a role for probucol?
    Bilheimer DW
    Am J Cardiol; 1986 Jun; 57(16):7H-15H. PubMed ID: 3637051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of apolipoprotein C-II-deficient triacylglycerol-rich lipoproteins and trioleoylglycerol/phosphatidylcholine-stabilized particles as substrates for lipoprotein lipase.
    Jackson RL; Tajima S; Yamamura T; Yokoyama S; Yamamoto A
    Biochim Biophys Acta; 1986 Feb; 875(2):211-9. PubMed ID: 3942763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the mechanism of hypertriglyceridemia in Tangier disease. Determination of plasma lipolytic activities, k1 values and apolipoprotein composition of the major lipoprotein density classes.
    Wang CS; Alaupovic P; Gregg RE; Brewer HB
    Biochim Biophys Acta; 1987 Jul; 920(1):9-19. PubMed ID: 3109493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on the binding and degradation of human very-low-density lipoproteins by human hepatoma cell line HepG2.
    Dashti N; Wolfbauer G
    Biochim Biophys Acta; 1986 Feb; 875(3):473-86. PubMed ID: 3004589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Action of ciprofibrate in type IIb hyperlipoproteinemia: modulation of the atherogenic lipoprotein phenotype and stimulation of high-density lipoprotein-mediated cellular cholesterol efflux.
    Guerin M; Le Goff W; Frisdal E; Schneider S; Milosavljevic D; Bruckert E; Chapman MJ
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3738-46. PubMed ID: 12915663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding of lipoprotein lipase to apolipoprotein B-containing lipoproteins.
    Carrero P; Gómez-Coronado D; Olivecrona G; Lasunción MA
    Biochim Biophys Acta; 1996 Jan; 1299(2):198-206. PubMed ID: 8555265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paradoxical exacerbation of combined hyperlipidemia in human apolipoprotein A-II transgenic mice treated with fenofibrate.
    Ribas V; Palomer X; Roglans N; Rotllan N; Fievet C; Tailleux A; Julve J; Laguna JC; Blanco-Vaca F; Escolà-Gil JC
    Biochim Biophys Acta; 2005 Dec; 1737(2-3):130-7. PubMed ID: 16226489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The carboxy-terminal domain of lipoprotein lipase induces cellular catabolism of normal very low density lipoproteins via the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor.
    Chappell DA; Inoue I; Fry GL; Pladet MW; Iverius PH; Lalouel JM; Strickland DK
    Ann N Y Acad Sci; 1994 Sep; 737():434-8. PubMed ID: 7944148
    [No Abstract]   [Full Text] [Related]  

  • 40. Influence of bezafibrate, fenofibrate, nicotinic acid and etofibrate on plasma high-density lipoprotein levels.
    Paoletti R; Franceschini G; Sirtori CR
    Am J Cardiol; 1983 Aug; 52(4):21B-27B. PubMed ID: 6351577
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.